Clinical trial
SPECT Study With SB-773812 In Schizophrenic Patients
NCT00269035
Study timeline
Study start (actual)2005-06-21Date precision: day
Registry last updated2017-08-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
SB773812DRUG
RisperidoneDRUG · verified · RxNorm: risperidone
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00269035 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.